The role of the public sector and philanthropy in vaccine development
Ian Gust
Microbiology Australia
32(3) 129 - 129
Published: 01 September 2011
Abstract
Vaccine development is now big business, with the global market, which is dominated by five research-based companies, growing at around 12% per annum and estimated to reach US$50 billion by 2016.https://doi.org/10.1071/MA11129
© CSIRO 2011
